Scott Peterson

3.8k total citations
60 papers, 2.9k citations indexed

About

Scott Peterson is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Scott Peterson has authored 60 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 26 papers in Oncology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Scott Peterson's work include HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and DNA Repair Mechanisms (10 papers). Scott Peterson is often cited by papers focused on HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and DNA Repair Mechanisms (10 papers). Scott Peterson collaborates with scholars based in United States, Japan and Australia. Scott Peterson's co-authors include William S. Dynan, David J. Chen, Arik Dvir, Akihiro Kurimasa, Mark W. Knuth, Hua Lu, Richard L. Bednar, E. Morton Bradbury, Michael D. Story and Robert B. Cary and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Scott Peterson

60 papers receiving 2.8k citations

Peers

Countries citing papers authored by Scott Peterson

Since Specialization

Citations

This map shows the geographic impact of Scott Peterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Peterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Peterson more than expected).

Fields of papers citing papers by Scott Peterson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Peterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Peterson. The network helps show where Scott Peterson may publish in the future.

Co-authorship network of co-authors of Scott Peterson

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Peterson. A scholar is included among the top collaborators of Scott Peterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Peterson. Scott Peterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HER2-Selective and Reversible Tyrosine Kinase Inhibitor Tucatinib Potentiates the Activity of T-DM1 in Preclinical Models of HER2-positive Breast Cancer 2023 ·Cancer Research Communications ·(unknown), (unknown), (unknown), Kelly Hensley, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michelle Ulrich, Scott Peterson, Anita Kulukian	6
2	Nonfucosylation of an anti-TIGIT antibody enhances FcγR engagement, driving innate immune activation and antitumor activity 2023 ·Frontiers in Immunology ·Alyson Smith, Robert E. Thurman, Weiping Zeng, (unknown), (unknown), Guadalupe Gutierrez, Ryan A. Heiser, (unknown), (unknown), Scott Peterson, Shyra J. Gardai	3
3	Mechanistic Modeling of Central Nervous System Pharmacokinetics and Target Engagement of HER2 Tyrosine Kinase Inhibitors to Inform Treatment of Breast Cancer Brain Metastases 2022 ·Clinical Cancer Research ·Jing Li, Jun Jiang, Xun Bao, Vineet Kumar, Stephen C. Alley, Scott Peterson, Anthony Lee	19
4	Engineering of a Potent, Long-Acting NPY2R Agonist for Combination with a GLP-1R Agonist as a Multi-Hormonal Treatment for Obesity 2020 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), David Huang, (unknown), Vân Nguyên-Trân, Sean B. Joseph, Shane Roller, Scott Peterson, (unknown), Matthew S. Tremblay, Peter G. Schultz, Weijun Shen	19
5	Preclinical Activity of HER2-Selective Tyrosine Kinase Inhibitor Tucatinib as a Single Agent or in Combination with Trastuzumab or Docetaxel in Solid Tumor Models 2020 ·Molecular Cancer Therapeutics ·Anita Kulukian, Patrice Lee, (unknown), Robert Rosler, Peter de Vries, Daniel Watson, Andres Forero‐Torres, Scott Peterson	144
6	295P Physiologically based pharmacokinetic (PBPK) modeling of the central nervous system (CNS) pharmacokinetics of tucatinib in patients with breast cancer brain metastasis 2020 ·Annals of Oncology ·Anthony Lee, Jun Jiang, Vineet Kumar, Stephen C. Alley, Scott Peterson, J. Li	4
7	Microaneurysm (MA) Wall Characteristics on Adaptive Optics Scanning Laser Ophthalmoscopy (AOSLO) are Related to MA Perfusion Status and Local Neural Retina Changes over Time 2017 ·Investigative Ophthalmology & Visual Science ·(unknown), Yang Lu, Scott Peterson, Konstantina Sampani, (unknown), Charles L. Cai, Ward Fickweiler, Paolo Silva, Lloyd Paul Aiello, Jennifer K. Sun	1
8	Evaluation of drug-drug interactions (DDI) between tucatinib and capecitabine (C) in patients with advanced HER2+ metastatic breast cancer from a phase 1b study 2017 ·Annals of Oncology ·Alex Vo, Dina Leviten, Michael A. Insko, (unknown), (unknown), Luke Walker, Scott Peterson	1
9	A phase II, open label study of tucatinib (ONT-380) combined with trastuzumab in patients with HER2+ metastatic colorectal cancer (mCRC)(MOUNTAINEER). 2017 ·Journal of Clinical Oncology ·John H. Strickler, Donna Niedzwiecki, Tyler Zemla, Andrea Cercek, Marwan Fakih, Kimmie Ng, Federico Augusto Sanchez, Christina Wu, Scott Peterson, (unknown), Axel Grothey, Tanios Bekaii‐Saab	11
10	A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours 2013 ·British Journal of Cancer ·Daniel W. Bowles, (unknown), Neil Senzer, Julie R. Brahmer, Alex A. Adjei, Michael A. Davies, Alexander J. Lazar, Alex Vo, Scott Peterson, Luke Walker, Diana F. Hausman, Charles M. Rudin, Antonio Jimeno	53
11	A Multicenter Phase I Trial of PX-866, an Oral Irreversible Phosphatidylinositol 3-Kinase Inhibitor, in Patients with Advanced Solid Tumors 2012 ·Clinical Cancer Research ·David S. Hong, Daniel W. Bowles, Gerald S. Falchook, Wells A. Messersmith, Goldy C. George, Cindy L. O’Bryant, Alex Vo, Kevin Klucher, Roy S. Herbst, Sabine Eckhardt, Scott Peterson, Diana F. Hausman, Razelle Kurzrock, Antonio Jimeno	134
12	A Nondenaturing Purification Scheme for the DNA-Binding Domain of Poly(ADP-Ribose) Polymerase, a Structure-Specific DNA-Binding Protein 1998 ·Protein Expression and Purification ·Tracy Ruscetti, Janet Newman, Thomas S. Peat, (unknown), (unknown), Thomas C. Terwilliger, Scott Peterson, Bruce E. Lehnert	5
13	Case 2: Pelvic fracture with tear of the left internal pudendal artery. 1998 ·American Journal of Roentgenology ·Michael H. Wholey, Scott Peterson, (unknown)	3
14	Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints 1998 ·Oncogene ·Guofeng Xie, Robert C. Habbersett, (unknown), Scott Peterson, Bruce E. Lehnert, E. Morton Bradbury, Joseph A. D'Anna	57
15	Characterization of Two DNA Double-stranded Break Repair-deficient Cell Lines That Express Inactive DNA-dependent Protein Kinase Catalytic Subunits 1997 ·Journal of Biological Chemistry ·Scott Peterson, Murray Stackhouse, (unknown), Fanqing Chen, Koki Sato, David J. Chen	36
16	Ku80 gene expression is Sp1-dependent and sensitive to CpG methylation within a novel cis element 1997 ·Gene ·Dale L. Ludwig, (unknown), Scott Peterson, André Nussenzweig, Gloria C. Li, D.J. Chen	37
17	Disruption of DNA-PK in Ku80 mutant xrs-6 and the implications in DNA double-strand break repair 1996 ·Mutation Research/DNA Repair ·Fanqing Chen, Scott Peterson, Michael D. Story, David J. Chen	63
18	CDK4/Cyclin D1/PCNA Complexes during Staurosporine-Induced G1 Arrest and G0 Arrest of Human Fibroblasts 1995 ·Experimental Cell Research ·Donna M. Gadbois, Scott Peterson, E. Morton Bradbury, Bruce E. Lehnert	17
19	Effects of rhIGF-I administration on bone turnover during short-term fasting. 1995 ·Journal of Clinical Investigation ·Steven Grinspoon, Howard B. A. Baum, Scott Peterson, Anne Klibanski	92
20	Traumatic hemothorax: Is decortication necessary? 1979 ·Journal of Thoracic and Cardiovascular Surgery ·James M. Wilson, (unknown), Scott Peterson, Arthur N. Thomas	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact